Inhibrx Biosciences, Inc. announced a private placement that it has issued 1,838 shares of common stock and warrants to purchase 7,354 shares of common stock at a per share exercise price of $17 per share on May 29, 2024. The transaction will include participation from new investor, Oxford Finance LLC.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.89 USD | -4.09% |
|
-9.03% | 0.00% |
06-24 | Inhibrx Biosciences, Inc.(NasdaqGS:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
05-30 | Inhibrx Biosciences, Inc.(NasdaqGS:INBX) added to S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 187M | |
+4.57% | 97.7B | |
+5.66% | 41.43B | |
-12.80% | 32.85B | |
+80.99% | 29.33B | |
-15.53% | 15.47B | |
-8.70% | 12.89B | |
-12.22% | 11.51B | |
+183.25% | 10.74B | |
+3.60% | 8.97B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx Biosciences, Inc.
- Inhibrx Biosciences, Inc. announced that it has received funding from Oxford Finance LLC